{
  "symbol": "IMP",
  "data_source": "VCI",
  "data_period": "year",
  "last_updated": "2025-12-25T12:35:06.526809",
  "name": "Công ty Cổ phần Dược phẩm IMEXPHARM",
  "exchange": "HSX",
  "sector": "Y tế",
  "shares_outstanding": 154042762.0,
  "charter_capital": 1540427620000.0,
  "revenue": 2512786046784.0,
  "revenue_ttm": 2512786046784.0,
  "net_income": 320862393082.0,
  "net_income_ttm": 320862393082.0,
  "total_assets": 2504776666933.0,
  "total_equity": 2183119168600.0,
  "total_liabilities": 321657498333.0,
  "total_debt": 321657498333.0,
  "current_assets": 1409543678165.0,
  "current_liabilities": 321657498333.0,
  "cash": 161983318837.0,
  "accounts_receivable": 383735262487.0,
  "fixed_assets": 858811130518.0,
  "ppe": 858811130518.0,
  "pe_ratio": 21.2993081954,
  "pb_ratio": 3.5087469642,
  "ps_ratio": 3.1462895125,
  "ev_ebitda": 13.5887128689,
  "pcf": -221.9236612028,
  "eps_ttm": 2352.1890730164,
  "bvps": 14278.6015951007,
  "dividend_per_share": 0.0,
  "roe": 16.55683077,
  "roa": 12.697831670000001,
  "roic": 18.56542272,
  "net_profit_growth": 6.190922089273951,
  "net_profit_margin": 13.406236578671427,
  "net_margin": 13.406236578671427,
  "gross_profit_margin": 39.55437248105663,
  "gross_margin": 39.55437248105663,
  "ebit_margin": 18.63183776245605,
  "operating_margin": 18.63183776245605,
  "current_ratio": 2.8070826056,
  "quick_ratio": 1.534796691,
  "cash_ratio": 0.2936130797,
  "interest_coverage": -21.552822278747886,
  "debt_to_equity": 0.3494275123,
  "leverage_ratio": 0.2469022464,
  "asset_turnover": 0.859599948,
  "fixed_asset_turnover": 2.9496107554,
  "avg_collection_period": 58.88042245152538,
  "days_sales_outstanding": 173.4112111793,
  "days_payable_outstanding": 29.9590837888,
  "cash_conversion_cycle": 262.2507174196254,
  "revenue_growth": 9.528244384530131,
  "market_cap": 7715848996200.0,
  "ebitda": 582479860758.0,
  "ebit": 106863308902.0,
  "inventory_turnover": 2.1048235435,
  "current_price": 50000.0,
  "working_capital": 1087886179832.0
}